Epidermolysis bullosa and the COVID-19 pandemic: challenges and recommendations.

Vahidnezhad, Hassan; Moravvej, Hamideh; Bahmanjahromi, Ayda; Youssefian, Leila; Abdollahimajd, Fahimeh

Vahidnezhad, Hassan; Moravvej, Hamideh; Bahmanjahromi, Ayda; Youssefian, Leila; Abdollahimajd, Fahimeh.

Vahidnezhad H; Department of Dermatology and Cutaneous Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.
Moravvej H; Jefferson Institute of Molecular Medicine, Thomas Jefferson University, Philadelphia, PA, USA.
Bahmanjahromi A; Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Youssefian L; Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abdollahimajd F; Department of Dermatology and Cutaneous Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.

J Dermatolog Treat ; 33(2): 1178-1179, 2022 03.

Article in English | MEDLINE | ID: covidwho-616052

Subject(s)

COVID-19; Epidermolysis Bullosa Dystrophica; Epidermolysis Bullosa; Humans; Pandemics

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Epidermolysis Bullosa Dystrophica / Epidermolysis Bullosa / COVID-19 Limits: Humans Language: English Journal: J Dermatolog Treat Journal subject: Dermatology Year: 2022 Document Type: Article Affiliation country: United States

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google